COVID-19 vaccine volunteers share their stories, one year later nocred COVID-19 vaccine volunteers share their stories, one year later On the one-year anniversary of the COVID-19 vaccine authorizations, Penn Medicine highlights the volunteers who played a critical role in providing much needed hope, in addition to crucial data showing the safety and effectiveness of the vaccines.
Four things to know about COVID-19 vaccine boosters This week at the Pottruck gym, Penn is running a vaccine booster clinic for students, faculty, staff, and postdocs. Four things to know about COVID-19 vaccine boosters Amidst concerns about increased positivity rates and new variants, Penn Today shares expert insights on the importance of COVID-19 vaccine boosters during the current phase of the pandemic.
UPenn chief medical officer: Pa. schools should keep enforcing masks, regardless of court decision Philadelphia Inquirer UPenn chief medical officer: Pa. schools should keep enforcing masks, regardless of court decision PJ Brennan, chief medical officer of the University of Pennsylvania Health System, wrote an opinion piece encouraging schools to continue to require masking in spite of the recent Pennsylvania Supreme Court’s decision to lift the state’s school mask mandate. “Whatever the underlying legal principles on the administration’s authority, lifting school masking mandates will further propagate the idea that the pandemic is past and leave us more vulnerable,” he wrote. Pfizer’s COVID pill works well, company confirms in final analysis The New York Times Pfizer’s COVID pill works well, company confirms in final analysis Sara Cherry of the Perelman School of Medicine commented on the results of a clinical trial of Pfizer’s antiviral pill, which was found to reduce death and hospitalizations by 88% in unvaccinated people. “This is quite amazing and potentially transformative,” she said. “If we could keep people out of hospitals, that would have a huge impact on health care.” How a perfect storm of factors led to ‘the mother of all supply chain disruptions’ (Homepage image) Because the shipping process is so complex, Steve Viscelli says, most of the operators in the chain need to be operating at 24 hours a day for the November order from President Joe Biden to be maximally effective. How a perfect storm of factors led to ‘the mother of all supply chain disruptions’ Penn experts reflect on the global supply chain snags that have stressed systems during the fall and holiday season. Vaccine makers racing to update COVID shots, just in case U.S. News & World Report Vaccine makers racing to update COVID shots, just in case While the available COVID-19 shots are still useful, companies are beginning to update their formulas in response to emerging variants. “Whether it turns out to be a false alarm, it would be really good to know if we can actually do this—get a new vaccine rolled out and be ready,” said E. John Wherry of the Perelman School of Medicine. Biden administration aims to make at-home COVID-19 tests more available; critics cite flaws KYW Newsradio (Philadelphia) Biden administration aims to make at-home COVID-19 tests more available; critics cite flaws Judith O’Donnell of the Perelman School of Medicine said there are a number of quality COVID-19 rapid tests available in the U.S. “Being able to do a test in your own house, rather than having to schedule an appointment to go to an urgent care center or go to an emergency room or to a testing site, is a level of convenience that we didn't have a year ago,” she said. New COVID pills offer hope as Omicron looms The New York Times New COVID pills offer hope as Omicron looms Sarah Cherry of the Perelman School of Medicine welcomed the arrival of two new antiviral drugs for COVID-19, which she said will be particularly helpful if the Omicron variant reduces the effectiveness of the vaccines. “That will definitely help us as a stopgap, if we really do need to change the vaccines,” she said. Four big questions about Omicron The New York Times Four big questions about Omicron Aaron Richterman of the Perelman School of Medicine said scientists aren’t yet sure if the Omicron variant is more likely to cause severe COVID-19 than other variants. “We may just not have had enough time to see severe disease develop,” he said. A chewing gum that could reduce SARS-CoV-2 transmission A chewing gum that could reduce SARS-CoV-2 transmission In experiments using saliva samples from COVID-19 patients, the gum, which contains the ACE2 protein, neutralized the virus, according to research led by School of Dental Medicine scientists. Load More
Pfizer’s COVID pill works well, company confirms in final analysis The New York Times Pfizer’s COVID pill works well, company confirms in final analysis Sara Cherry of the Perelman School of Medicine commented on the results of a clinical trial of Pfizer’s antiviral pill, which was found to reduce death and hospitalizations by 88% in unvaccinated people. “This is quite amazing and potentially transformative,” she said. “If we could keep people out of hospitals, that would have a huge impact on health care.” How a perfect storm of factors led to ‘the mother of all supply chain disruptions’ (Homepage image) Because the shipping process is so complex, Steve Viscelli says, most of the operators in the chain need to be operating at 24 hours a day for the November order from President Joe Biden to be maximally effective. How a perfect storm of factors led to ‘the mother of all supply chain disruptions’ Penn experts reflect on the global supply chain snags that have stressed systems during the fall and holiday season. Vaccine makers racing to update COVID shots, just in case U.S. News & World Report Vaccine makers racing to update COVID shots, just in case While the available COVID-19 shots are still useful, companies are beginning to update their formulas in response to emerging variants. “Whether it turns out to be a false alarm, it would be really good to know if we can actually do this—get a new vaccine rolled out and be ready,” said E. John Wherry of the Perelman School of Medicine. Biden administration aims to make at-home COVID-19 tests more available; critics cite flaws KYW Newsradio (Philadelphia) Biden administration aims to make at-home COVID-19 tests more available; critics cite flaws Judith O’Donnell of the Perelman School of Medicine said there are a number of quality COVID-19 rapid tests available in the U.S. “Being able to do a test in your own house, rather than having to schedule an appointment to go to an urgent care center or go to an emergency room or to a testing site, is a level of convenience that we didn't have a year ago,” she said. New COVID pills offer hope as Omicron looms The New York Times New COVID pills offer hope as Omicron looms Sarah Cherry of the Perelman School of Medicine welcomed the arrival of two new antiviral drugs for COVID-19, which she said will be particularly helpful if the Omicron variant reduces the effectiveness of the vaccines. “That will definitely help us as a stopgap, if we really do need to change the vaccines,” she said. Four big questions about Omicron The New York Times Four big questions about Omicron Aaron Richterman of the Perelman School of Medicine said scientists aren’t yet sure if the Omicron variant is more likely to cause severe COVID-19 than other variants. “We may just not have had enough time to see severe disease develop,” he said. A chewing gum that could reduce SARS-CoV-2 transmission A chewing gum that could reduce SARS-CoV-2 transmission In experiments using saliva samples from COVID-19 patients, the gum, which contains the ACE2 protein, neutralized the virus, according to research led by School of Dental Medicine scientists. Load More
How a perfect storm of factors led to ‘the mother of all supply chain disruptions’ (Homepage image) Because the shipping process is so complex, Steve Viscelli says, most of the operators in the chain need to be operating at 24 hours a day for the November order from President Joe Biden to be maximally effective. How a perfect storm of factors led to ‘the mother of all supply chain disruptions’ Penn experts reflect on the global supply chain snags that have stressed systems during the fall and holiday season.
Vaccine makers racing to update COVID shots, just in case U.S. News & World Report Vaccine makers racing to update COVID shots, just in case While the available COVID-19 shots are still useful, companies are beginning to update their formulas in response to emerging variants. “Whether it turns out to be a false alarm, it would be really good to know if we can actually do this—get a new vaccine rolled out and be ready,” said E. John Wherry of the Perelman School of Medicine. Biden administration aims to make at-home COVID-19 tests more available; critics cite flaws KYW Newsradio (Philadelphia) Biden administration aims to make at-home COVID-19 tests more available; critics cite flaws Judith O’Donnell of the Perelman School of Medicine said there are a number of quality COVID-19 rapid tests available in the U.S. “Being able to do a test in your own house, rather than having to schedule an appointment to go to an urgent care center or go to an emergency room or to a testing site, is a level of convenience that we didn't have a year ago,” she said. New COVID pills offer hope as Omicron looms The New York Times New COVID pills offer hope as Omicron looms Sarah Cherry of the Perelman School of Medicine welcomed the arrival of two new antiviral drugs for COVID-19, which she said will be particularly helpful if the Omicron variant reduces the effectiveness of the vaccines. “That will definitely help us as a stopgap, if we really do need to change the vaccines,” she said. Four big questions about Omicron The New York Times Four big questions about Omicron Aaron Richterman of the Perelman School of Medicine said scientists aren’t yet sure if the Omicron variant is more likely to cause severe COVID-19 than other variants. “We may just not have had enough time to see severe disease develop,” he said. A chewing gum that could reduce SARS-CoV-2 transmission A chewing gum that could reduce SARS-CoV-2 transmission In experiments using saliva samples from COVID-19 patients, the gum, which contains the ACE2 protein, neutralized the virus, according to research led by School of Dental Medicine scientists. Load More
Biden administration aims to make at-home COVID-19 tests more available; critics cite flaws KYW Newsradio (Philadelphia) Biden administration aims to make at-home COVID-19 tests more available; critics cite flaws Judith O’Donnell of the Perelman School of Medicine said there are a number of quality COVID-19 rapid tests available in the U.S. “Being able to do a test in your own house, rather than having to schedule an appointment to go to an urgent care center or go to an emergency room or to a testing site, is a level of convenience that we didn't have a year ago,” she said. New COVID pills offer hope as Omicron looms The New York Times New COVID pills offer hope as Omicron looms Sarah Cherry of the Perelman School of Medicine welcomed the arrival of two new antiviral drugs for COVID-19, which she said will be particularly helpful if the Omicron variant reduces the effectiveness of the vaccines. “That will definitely help us as a stopgap, if we really do need to change the vaccines,” she said. Four big questions about Omicron The New York Times Four big questions about Omicron Aaron Richterman of the Perelman School of Medicine said scientists aren’t yet sure if the Omicron variant is more likely to cause severe COVID-19 than other variants. “We may just not have had enough time to see severe disease develop,” he said. A chewing gum that could reduce SARS-CoV-2 transmission A chewing gum that could reduce SARS-CoV-2 transmission In experiments using saliva samples from COVID-19 patients, the gum, which contains the ACE2 protein, neutralized the virus, according to research led by School of Dental Medicine scientists. Load More
New COVID pills offer hope as Omicron looms The New York Times New COVID pills offer hope as Omicron looms Sarah Cherry of the Perelman School of Medicine welcomed the arrival of two new antiviral drugs for COVID-19, which she said will be particularly helpful if the Omicron variant reduces the effectiveness of the vaccines. “That will definitely help us as a stopgap, if we really do need to change the vaccines,” she said. Four big questions about Omicron The New York Times Four big questions about Omicron Aaron Richterman of the Perelman School of Medicine said scientists aren’t yet sure if the Omicron variant is more likely to cause severe COVID-19 than other variants. “We may just not have had enough time to see severe disease develop,” he said. A chewing gum that could reduce SARS-CoV-2 transmission A chewing gum that could reduce SARS-CoV-2 transmission In experiments using saliva samples from COVID-19 patients, the gum, which contains the ACE2 protein, neutralized the virus, according to research led by School of Dental Medicine scientists. Load More
Four big questions about Omicron The New York Times Four big questions about Omicron Aaron Richterman of the Perelman School of Medicine said scientists aren’t yet sure if the Omicron variant is more likely to cause severe COVID-19 than other variants. “We may just not have had enough time to see severe disease develop,” he said. A chewing gum that could reduce SARS-CoV-2 transmission A chewing gum that could reduce SARS-CoV-2 transmission In experiments using saliva samples from COVID-19 patients, the gum, which contains the ACE2 protein, neutralized the virus, according to research led by School of Dental Medicine scientists.
A chewing gum that could reduce SARS-CoV-2 transmission A chewing gum that could reduce SARS-CoV-2 transmission In experiments using saliva samples from COVID-19 patients, the gum, which contains the ACE2 protein, neutralized the virus, according to research led by School of Dental Medicine scientists.